202 related articles for article (PubMed ID: 23328731)
1. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
[TBL] [Abstract][Full Text] [Related]
2. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
3. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
5. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
[TBL] [Abstract][Full Text] [Related]
6. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
[TBL] [Abstract][Full Text] [Related]
7. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
[TBL] [Abstract][Full Text] [Related]
8. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.
Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I
Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
[TBL] [Abstract][Full Text] [Related]
10. Fe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP
Li L; Tovmasyan A; Sheng H; Xu B; Sampaio RS; Reboucas JS; Warner DS; Batinic-Haberle I; Spasojevic I
Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32492872
[TBL] [Abstract][Full Text] [Related]
11. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D
Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Free Radic Biol Med; 2008 Mar; 44(6):982-9. PubMed ID: 18082148
[TBL] [Abstract][Full Text] [Related]
13. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
[TBL] [Abstract][Full Text] [Related]
14. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
[TBL] [Abstract][Full Text] [Related]
15. Intracellular targeting and pharmacological activity of the superoxide dismutase mimics MnTE-2-PyP5+ and MnTnHex-2-PyP5+ regulated by their porphyrin ring substituents.
Aitken JB; Shearer EL; Giles NM; Lai B; Vogt S; Reboucas JS; Batinic-Haberle I; Lay PA; Giles GI
Inorg Chem; 2013 Apr; 52(8):4121-3. PubMed ID: 23551184
[TBL] [Abstract][Full Text] [Related]
16. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
17. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD
Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774
[TBL] [Abstract][Full Text] [Related]
18. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.
Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I
Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.
Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757
[TBL] [Abstract][Full Text] [Related]
20. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
Rebouças JS; Spasojević I; Batinić-Haberle I
J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
